<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-pharmaceuticals-12-00147">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ghendon</surname>
    <given-names>Y.Z.</given-names>
   </name>
   <name>
    <surname>Markushin</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Akopova</surname>
    <given-names>I.I.</given-names>
   </name>
   <name>
    <surname>Koptiaeva</surname>
    <given-names>I.B.</given-names>
   </name>
   <name>
    <surname>Nechaeva</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Mazurkova</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Radaeva</surname>
    <given-names>I.F.</given-names>
   </name>
   <name>
    <surname>Kolokoltseva</surname>
    <given-names>T.D.</given-names>
   </name>
  </person-group>
  <article-title>Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine</article-title>
  <source>Vaccine</source>
  <year>2005</year>
  <volume>23</volume>
  <fpage>4678</fpage>
  <lpage>4684</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.04.039</pub-id>
  <?supplied-pmid 16026905?>
  <pub-id pub-id-type="pmid">16026905</pub-id>
 </element-citation>
</ref>
